What are the Benefits and Side Effects of TKIs?

News
Video

Related Videos
Jeffrey P. Townsend, PhD
Michael Iglesia, MD, PhD
Jean L. Koff, MD, MS
Rohan Garje, MD
Nan Chen, MD
Sundar Jagannath, MBBS
Video 10 -"Real-World Evidence on Second-Line Therapy Selection and Outcomes"
Video 9 - "Additional Second-Line Treatments for HCC"
Lori A. Leslie, MD
Related Content
Petros Grivas, MD, PhD, of Seattle Cancer Care Alliance

Grivas Spotlights Advances With Immunotherapy-Based Approaches in Urothelial Cancer

May 14th 2024
Article
Jubilee Brown, MD, professor, director, Gynecologic Oncology, Atrium Health Levine Cancer Institute

Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer

May 13th 2024
Podcast
Samilia Obeng-Gyasi, MD, MPH

Identifying Individual Social Determinants of Health Could Reduce Barriers to Breast Cancer Care

May 14th 2024
Article
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, professor, division head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; codirector, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors

May 9th 2024
Podcast
Jean L. Koff, MD, MS

Pirtobrutinib Transforms SOC in Later-Line CLL/SLL

May 14th 2024
Article
Susanna Hegewisch-Becker, MD, PhD

Relatlimab Plus Nivolumab/Chemo Misses ORR End Point in LAG-3+ Advanced Gastric/GEJ Cancer

May 14th 2024
Article